Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity

BACKGROUND: Triple-negative breast cancer (TNBC) remains recalcitrant to most targeted therapy approaches. However, recent clinical studies suggest that inducing tumor damage can render TNBC responsive to immunotherapy. We therefore tested a strategy for immune sensitization of murine TNBC (4T1 tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheybani, Natasha D, Witter, Alexandra R, Thim, Eric A, Yagita, Hideo, Bullock, Timothy N J, Price, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443308/
https://www.ncbi.nlm.nih.gov/pubmed/32819975
http://dx.doi.org/10.1136/jitc-2020-001008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443308/
https://www.ncbi.nlm.nih.gov/pubmed/32819975
http://dx.doi.org/10.1136/jitc-2020-001008

Ejemplares similares